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Abstract 
 
 
 
Background or Aim 
Despite guidelines and the International Classification of Headache Disorders (ICHD-
IIIβ) criteria, the diagnosis of common chronic headache disorders can be challenging 
for non-expert clinicians.   The aim of the review was to identify headache 
classification tools that could be used by a non-expert clinician to classify common 
chronic disorders in primary care. 
 
Methods 
We conducted a systematic literature review of studies validating diagnostic and 
classification headache tools published between Jan 1988 and June 2016 from key 
databases: MEDLINE, ASSIA, Embase, Web of Knowledge and PsycINFO.  Quality 
assessment was assessed using items of the Quality of Diagnostic Accuracy Studies 
(QUADAS-2). 
 
Results 
The search identified 38 papers reporting the validation of 30 tools designed to 
diagnose, classify or screen for headache disorders; nine for multiple headache types 
and 21 for one headache type only.  We did not identify a tool validated in a primary 
care that can be used by a non-expert clinician to classify common chronic headache 
disorders and screen for primary headaches other than migraine and TTH in primary 
care. 
 
Conclusions 
Despite the availability of many headache classification tools we propose the need 
for a tool which could support primary care clinicians diagnose and manage chronic 
headache disorders within primary care, and allow more targeted referral to 
headache specialists 
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Introduction 
Around 4% of primary care consultations and 30% of neurology outpatient 
appointments in the UK are due to headache disorders (1, 2).  Yet many patients 
presenting in primary care with headache do not have a formal diagnosis, are 
misdiagnosed, and can potentially receive inappropriate drug treatment and 
management. A study in the UK study found 70% presenting with new onset 
headache were not formally diagnosed (3) and 88% of patients with a history of 
sinus headache screened in primary care clinics in the US met International 
Headache Society criteria for migraine (4).    
Despite deceptively simple diagnostic criteria for different headache types such as  
the comprehensive headache classification ‘The International Classification of 
Headache Disorders, 3rd edition’ (5) and the National Institute for Health and Care 
Excellence (NICE) headache guidance (6), in reality, it can be challenging for a non-
expert clinician to accurately diagnose headache disorders.   
The Chronic Headache and Self-management Study (CHESS) is a National Institute for 
Health Research (NIHR) funded programme grant (project number RP-PG-1212-
20018) with the overall aim of developing and testing a self-management 
programme for people living with chronic headache; specifically tension type or 
migraine with or without medication overuse.  As part of the study we want to be 
able to classify participants’ chronic headache types to confirm eligibility, for 
reporting purposes, and as part of the study intervention to allow targeted 
treatment and advice.  Specifically we need a classification tool that can be used by a 
non-expert clinician to screen for secondary headache disorders and primary 
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headache disorders other than migraine and tension type headache (TTH), 
distinguish between chronic migraine and chronic TTH and identify medication 
overuse headache (MOH) in primary care settings.  We anticipate that such a tool 
could also support primary care clinicians diagnose and manage chronic headache 
disorders within primary care, and allow more targeted referral to headache 
specialists. 
We therefore conducted this systematic review to 1) identify any existing tools used 
to classify chronic headache disorders and 2) assess the validation of tools identified.   
 
Methods 
We registered this review prospectively with the International Prospective Register 
of Systematic Reviews. PROSPERO 2015: CRD42015019863.  It is available from 
http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42015019863 and 
we followed the PRISMA guidelines for the reporting of systematic reviews. (7). 
 
Search strategy and study selection 
We included studies that describe the validation of headache tools intended to 
diagnose, classify or screen for one or more headache types and compare with a 
reference standard.  We only included studies published in English and published 
from January 1988, the publication date of the first “International Classification of 
Headache Disorders (ICHD)”(5).  We excluded studies with participants aged below 
18 years and any dissertation and conference proceedings, plus those studies where 
the sole purpose of the study was to report the validation of a tool in a different 
language.  
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With the support of an academic support librarian, we searched key databases: 
MEDLINE, ASSIA, Embase, Web of Knowledge and PsycINFO. The searches were 
updated in June 2016.  We used free text and MeSH terms based on those used for 
NICE headache guidelines 2012(8); search words included: 
‘Headache’, ‘headache disorders’, ‘headache disorders primary’, ‘headache disorders 
secondary’, ‘migraine’, ‘migraine disorders’, ‘migraine with aura’, ‘migraine without 
aura’,  ‘tension headache’, ‘cluster headache’, ‘medication overuse headaches’ 
combined with ‘classification’, ‘diagnostic’, ‘diagnosis’, ‘diagnostic techniques and 
procedures’, ‘sensitivity’, specificity’, ‘efficacy’, ‘effectiveness’, ‘efficiency’, 
‘predictive value of tests’, ‘likelihood function’, ‘diagnostic odds ratio’, and  
‘screening,’ ‘questionnaire,’ ‘survey’, ‘interview as topic’ and ‘tools’, ‘instruments’ 
and ‘ICHD’.   
Results were managed using the Evidence for Policy and Practice Information and 
Co-ordinating Centre (EPPI Centre) reviewer 4 software, duplicates removed, and 
titles checked for relevance by two authors (RP, KP).  We sought a full copy of 
possible relevant papers, which were assessed independently for inclusion by two 
authors and any disagreement resolved by discussion. We checked reference lists of 
relevant papers for any additional studies. 
 
Data extraction and quality assessment 
Three authors (RP, CB, KP) independently extracted data from papers included in the 
review using a predetermined pro-forma to capture both study and tool specific 
information: study design, characteristics  of study participants, a brief description of 
the diagnostic or classification tool, test characteristics, diagnostic/classification 
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parameters, validation assessment (sensitivity, specificity), how the tool is used 
(questionnaire, online, interview) and by whom (expert, non-expert, patient).  
The same three authors independently assessed the methodological quality of each 
study using the Quality of Diagnostic Accuracy Studies (QUADAS-2), a validated tool 
used for the quality assessment of diagnostic accuracy studies (9).  
The QUADAS-2 assesses four domains for risk of bias: patient selection (sampling and 
exclusions), index test (conduct and interpretation), reference standard (conduct and 
interpretation), and flow and timing (interval between index and reference standard, 
number receiving reference standard and included in the analysis). The sets of 
signalling questions used for each domain have been tailored to the content of the 
review as recommended by the authors of the tool.  
We assessed risk of bias as low, high or unclear for each domain and calculated an 
overall risk of bias dependent on the number of domains judged as high risk of bias: 
0 domains = Low, 1= Low/medium, 2=Medium, 3=Medium/high, 4=High risk of bias.  
Where criteria used to judge risk for one of the domains was unclear, the risk was 
considered ‘high risk’ and this was denoted in the overall risk of bias.  
 
Results 
Study selection 
We identified 4348 records from the combined database searches and removed 
2459 duplicates.  The remaining 1889 records were screened for relevance and 1694 
records were excluded because they did not meet the study inclusion criteria.  We 
obtained the full text for 195 records and excluded 157 after reading the full paper 
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that did not meet the inclusion criteria, resulting in a total of 38 papers, validating 30 
different tools that we included in the review (figure 1).   
 
Study characteristics 
The 38 papers published between 1991 and 2016(10-47) report validation studies 
from 18 different countries, with most papers from the US (n=10) and Italy (n=4).  
The papers report the validation of 30 tools,  nine  to diagnose or classify more than 
one headache type and 21  to classify or screen for one headache type only: 
migraine (n=18), cluster headache (n=2), and probable medication overuse headache 
(n=1) (Table 1).   
The number of participants included in the validation studies ranges from 50 to 
9346. The majority of the tools are questionnaires, self-completed (n=17), completed 
face-to-face with a clinician or researcher (n=8), and self-complete online 
questionnaires (n=2). The three remaining tools are computerised decision support 
systems designed to assist clinical diagnosis. The number of items in the 
questionnaires range from short single item migraine screen tests (47) to a longer 76 
item questionnaire (10) plus the complex computerised diagnostic tools  (13, 14, 34).   
The tools have been validated in headache clinic settings (n=14) as part of general 
health or household surveys (n=6), neurology clinics or departments (n=5), primary 
care settings (n=4), emergency care (n=3), community (n=2) and other settings such 
as ophthalmology departments, temporomandibular joint and orofacial pain clinics, 
and obstetrics and gynaecology clinics (n=3), with some tools validated in more than 
one setting.  
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In most studies the reference standard used to validate the tool is a face-to-face 
neurological assessment by a headache specialist doctor based on the ICHD criteria 
used at the time of validation. Exceptions include where the reference standard is 
conducted by a headache nurse specialist experienced in headache diagnosis (34), 
primary care doctors trained to use IHS criteria for migraine (30) and 
researchers(47).  When reported, the time interval between the index test and 
reference standard is generally short (conducted on the same day, or within four 
weeks) although the longest interval reported was between two to three years (27).     
There is wide variation in the reporting of the psychometric results across studies 
with some reporting an overall sensitivity and/or specificity only, others reporting 
results for particular headache types, and with some studies also reporting positive 
and negative predictive values. We have reported the psychometric results for each 
study in table 1. 
Study Quality 
The quality assessment for risk of bias for the four QUADAS-2 domains: patient 
selection, index test, reference standard, flow and timing, plus an overall quality 
assessment are reported in table 3.  The overall risk of bias was low for five studies, 
low/medium for 16, medium for seven, medium/high for six studies and high for four 
studies.  
Multiple headache types  
We identified nine tools that diagnose or classify more than one headache type; 
three computerised decision support tools and six questionnaires. The three 
computerised diagnostic tools support clinical diagnosis of the common episodic and 
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chronic primary headache disorders migraine and TTH, trigeminal autonomic 
cephalagia (TAC) and medication overuse headache (MOH) (13, 14, 34).  The 
sensitivity of the computerised decision support tools appears to be good for most 
headache types, the authors report lower sensitivity for probable migraine and 
probable TTH(14) and new daily persistent headache (NDPH) (34).   All three tools 
have been validated in headache clinic populations; overall risk of bias is lowest for 
the study by Dong et al (2014) (14).     
The six questionnaires all classify the common primary headache disorders migraine 
and TTH plus MOH.  The 76 item Italian ICHD-II based questionnaire reports the 
highest sensitivity and specificity and has low risk of bias (10).  The HARDSHIP 
questionnaire, developed as part of a Global Campaign against Headache initiative, 
has been the most extensively validated, in different languages and cultures and is 
suitable to be administered by trained lay interviews; examples of studies using the 
questionnaire are presented in the table.  Sensitivity ranges from 63-85 and 
specificity 82-99 for migraine, and sensitivity 51-64 and specificity 51-64 for TTH 
across the four studies (India, China, Russia and Pakistan)(48).   
In addition to the common primary headache disorders migraine and TTH, one self-
complete questionnaire also screens for Trigeminal Autonomic Cephalagia (19), 
validated in a headache clinic population, authors report sensitivity 63.3 (52.9-72.7) 
and specificity 98.8 (96-99.8).     
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One headache type 
Cluster headache 
We identified two tools that screen for cluster headache, both self-completed 
questionnaires validated in headache clinic populations with low/medium risk of bias 
(16, 45).  The presence of 5 of 7 features (pain severity and location, duration < 3 to 
4 hours, frequency and daily reoccurrence of attacks, rhinorrhoea and restlessness) 
has high sensitivity 100 and specificity 95.1(45).   
Probable medication overuse headache 
We found one tool for the screening of probable medication over-use headache 
(pMOH)(15), validated in a headache clinic setting with low/medium risk of bias.  
Based on ICHD-II criteria for pMOH, three items were found to have sensitivity 81 
and specificity 100.  
Migraine 
We identified 18 tools designed to classify or screen for migraine: migraine only 
(n=10), migraine with and without aura (n=5), aura only (n=1), chronic migraine (n=1) 
and menstrual migraine (n=1). 
The majority of the migraine tools are short self-complete screening questionnaires; 
where authors have published the tool the most frequent items are shown in table 2.  
Notably there are no questions common to all tools, but questions to identify nausea 
and/or vomiting related to headache (n=7) and photophobia (n=7) are most frequent 
across the tools, followed by pain restricting activity (n=6), and phonophobia (n=5). 
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The most widely used and validated of the migraine tools is the ID Migraine with 
three questions on headache related disability, nausea and photophobia (31).  A 
previous meta-analysis of 13 studies reports sensitivity of 84 (95% CI, 75-90) and 
specificity 76 (95% CI 69-83)(49).  ID Migraine has been validated in different 
languages (not reported here) and different settings, including ENT and 
ophthalmology, and temporomandibular joint and orofacial pain clinics. (18, 26) 
The seven item Asian Migraine Criteria (AMC) reports the highest sensitivity and 
specificity (99.3 and 84.4), but medium/high* risk of bias(21).   The eight item 
Migraine Assessment Tool (MAT) reports good sensitivity and specificity (89 and 79) 
and low risk of bias.  
Not surprisingly the tools developed to identify migraine with or without aura, all 
self-completed questionnaires, tend to be longer, ranging from 10 questions to 56 
questions.   The shortest of these, The University of California-San Diego (UCSD) 
Migraine Questionnaire(44) report sensitivity and specificity for migraine with aura 
(71-81 and 100), migraine without aura (100 and 91-94) with low/medium risk of 
bias.  Whereas longer questionnaires where participants are asked to describe aura 
in their own words , (25) report higher sensitivity and specificity for migraine without 
aura (93-100 and 100) and migraine with aura (88-89 and 95-97) but has medium 
risk of bias(25).                                                        
The Visual Aura Rating Scale (VARS) (17) is intended to supplement the ICHD-II and 
captures visual aura symptoms and characteristics (e.g. location, scotoma, ziz-zag 
lines, duration, and gradually development).  Validated in a population already 
diagnosed with migraine with aura, sensitivity and specificity are high (91 and 96) 
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and methodological quality, medium* risk of bias.  
Identify Chronic Migraine (ID-CM) (50)is an online tool to help clinicians identify 
patients likely to have migraine, and in particular, chronic migraine. The authors 
report sensitivity and specificity for migraine (83.5 and 88.5) and for chronic 
migraine (80.6 and 88.6) risk of bias is low/medium.  
                                                                        
Discussion 
The review identified many papers validating headache diagnostic or classification 
tools.  The large number of tools identified indicates the demand for tools that can 
be used to support the diagnosis of headache disorders clinically and/or allow the 
classification of headache disorders in research.  
More than half of the papers (n=21) were judged to have low or low/medium risk of 
bias for overall quality. The risk of bias was judged high most frequently for the 
QUADAS-2 domain ‘flow and timing’ which assesses the interval between collecting 
the index and reference standard, the number of participants receiving the same 
reference standard and whether all participants were included in the analysis. The 
criteria used to judge the risk of bias was unclear for at least one domain in 23 
papers and recorded as ‘high risk’, indicating that quality assessment often reflects 
bias in reporting rather than bias in the conduct of the study.  Most of the tools 
identified in the review have been tested in one setting only, predominantly in 
headache clinic populations.  Exceptions include the Hardship tool, which has been 
validated in different languages and cultures, and the ID-migraine, which has been 
validated extensively in different languages and settings. 
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The overriding purpose of the review was driven by our own research requirements, 
that is, to identify existing headache classification tools that can be used by a non-
expert clinician in primary care to classify chronic headache disorders; and 
specifically to identify tools that allow the user to screen for secondary headache 
disorders and primary headache disorders other than migraine and tension type 
headache (TTH), distinguish between chronic migraine and chronic TTH and identify 
medication overuse headache (MOH).  We anticipate that such a tool could also 
support primary care clinicians diagnose and manage chronic headache disorders 
within primary care more effectively.   
We identified six tools that allow the user to screen for primary headache disorders 
other than migraine and TTH; four to identify trigemal autonomic cephalagias (TACs) 
and two specifically for cluster headache. The three computerised diagnostic tools 
appear to perform well for identification of TACs, as does the longer of the cluster 
headache specific questionnaires(45).  Only one of the computerised diagnostic tools 
was designed and validated for use by a non-expert clinician, but to date has not 
been validated in primary care (14).  
The HARDSHIP questionnaire is the most extensively validated of the tools that 
allows the distinction between chronic migraine and chronic TTH by a non- expert 
clinician; the questionnaire was not designed to identify other primary headache 
types.  The Identify Chronic Migraine (ID-CM) tool helps clinicians identify patients 
likely to have migraine, and in particular, chronic migraine; but does not allow the 
classification of other chronic headache types.  More commonly the tools identified 
in the review classify episodic rather than chronic headache, with 17 screening for 
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episodic migraine.  It is interesting to note that where authors have published the 
tool no question is common to all tools.  
The review also identified a number of tools that classify medication overuse 
headache including a brief self-complete questionnaire adapted from ICHD-II for 
MOH with sensitivity 81 and specificity 100(15). 
We identified a large number of good quality studies, validating a wide range of 
different headache classification tools; and the review provides a comprehensive 
evaluation and summary of tools that researchers and clinicians can use to classify 
headache disorders.  However we did not identify a tool suitable for our own 
research needs, specifically a tool validated in a primary care setting and could be 
used by a non- expert clinician in primary care to support the diagnosis of common 
chronic headache disorders and screen for primary headache disorders other than 
migraine and TTH.  We propose that such a tool could potentially support more 
targeted referral to headache specialists and free up under-resourced neurology 
departments (2).  
Strengths 
We searched for tools that diagnose, classify or screen for all headache types rather 
than restrict the search to tools for chronic headache only. All data extractions and 
quality assessments were double coded independently by three reviewers and 
agreement checked; and we used the established tool QUADAS-2 to assess the 
quality of studies. 
Limitations 
Our search strategy used MeSH terms based on the search terms used to develop 
NICE headache guidelines to identify potential validation studies, but it is possible 
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that some studies were missed.  Reporting of psychometric results made it difficult 
to compare across studies. 
Conclusions 
Diagnosis of chronic headache disorders can be challenging for non-expert clinicians.  
Depending on the clinical, or research, need there are a number of adequate tools 
available that could be used in specific contexts.  Nevertheless, there are currently 
no tools validated in primary care that can be used by a non-expert clinicians to 
classify chronic headache disorders that also allow the user to screen for primary 
headaches other than migraine and TTH.  The availability of such a tool could 
support primary care clinicians diagnose and manage chronic headache disorders 
within primary care, and allow more targeted referral to headache specialists. 
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Table 1.   
Name and brief 
description of tool 
Type of tool 
(reported) 
Author/year  Country Study Setting Reference test Psychometric results           
Sensitivity (%), Specificity 
(%), Positive (PPV) value 
(%) Negative predictive 
values (NPV) (%) 
Multiple Headache Types 
AIDA Cefalee computer-
assisted diagnostic 
expert system based on 
the ICHD-II to support 
diagnostic accuracy once 
all clinical characteristics 
collected by medical 
staff. Headaches 
identified: migraine 
(with aura, without 
aura, TTH, trigeminal-
autonomic cephalalgias 
Diagnostic De Simone, 
R. (2007) 
Italy  
 
 
Clinical records of 
previously diagnosed 
primary headache cases 
from headache centres 
(n=200) 
Structured interview 
by medical staff 
working at headache 
centre using ICHD-II 
criteria 
Overall sensitivity 98.5%  
Computerised clinical 
decision support system 
(CDSS) based on ICHD-
III to help community 
doctors, GPs and 
Diagnostic Dong, Z. et al 
(2014) 
China  Patients from a headache 
centre     (n=543) 
Headache specialists 
used the information 
entered into the 
CDSS to made their 
Reported for each 
headache type                                      
Sensitivity range 60.9-100, 
(low for probable 
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inexperienced 
physicians to simplify 
clinical diagnosis.  
Headaches identified: 
migraine (with, without 
aura, chronic and 
probable)TTH (episodic, 
chronic, probable), 
cluster headache 
(probable), medication 
overuse headache and 
'others' 
own 'gold standard' 
diagnosis 
migraine and probable 
TTH)     
Cluster headache 90 
NDPH 100                                          
Specificity 97.9-100                         
PPV 73. 7 -100                                       
NPV 95.6 -100                                  
Computerised Headache 
Assessment Tool (CHAT) 
online self –assessment 
reviewed with a doctor. 
Diagnosis based on IHS 
criteria to identify: 
episodic, probable and 
transformed migraine, 
new daily persistent 
headache, episodic and 
chronic tension-type 
headache, cluster 
headache, MOH.   
Diagnostic Maizels, M. 
& Wolfe, J. 
(2008) 
US Convenience sample of 
patients presenting with 
headache at an urgent care 
department, plus patients 
from a family practice 
waiting room (n=117) 
Telephone interview 
by headache 
specialist nurse 
based on validated 
diagnostic tools and 
IHS criteria 
Sensitivity  
Overall 88.9 (excluding 
MOH) 
Migraine 94.4  
Daily headache 92.6 
Medication overuse 82.7 
Cluster headache 100 
NDPH 42.9 
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Headache-Attributed 
Restriction, Disability, 
Social Handicap and 
Impaired Participation 
(HARDSHIP) 
questionnaire  
Diagnosis of migraine, 
TTH or MOH generated 
by a computerised 
algorithm. The most 
bothersome headache 
type is diagnosed. 
Interview conducted by 
a trained non-medical 
interviewer  
Diagnostic 
(module within 
questionnaire) 
Ayzenberg, I. 
et al (2011) 
Russia A sub-sample of 
respondents completing the 
who had be randomly 
selected  from four cities 
and three rural areas of 
Russia (n=190) 
Telephone interview 
by neurologist using 
expertise and ICHD-II 
criteria 
Sensitivity 
Migraine 76.9 (68.1-84.0)               
TTH 64.0 (57.9-68.4) 
Specificity 
Migraine 82.4 (77.8-86.1)                   
TTH 91.1 (85.6-94.9) 
PPV 
Migraine 69.4 (61.5-75.8)    
TTH 86.4 (78.0-77.3) 
NPV 
Migraine 87.3 (82.4-91.2)              
TTH 74.2 (69.8-77.3) 
HARDSHIP 
questionnaire  
 Herekar, A et 
al (2013) 
Pakistan Consecutive sample 
recruited from three (urban 
and rural) medical sites 
(n=180). Included patients 
reporting headache 
disorder and their 
attendants (i.e. non-
patients) 
Face-to-face 
interview using the 
ICHD-II criteria, 
conducted by a 
neurologist (expert 
in headaches) 
Sensitivity                               
Migraine: 74; TTH 60; 
headache on more than 
15 days 98; probable 
MOH 86                                        
Specificity                                     
Migraine: 87; TTH 92; 
headache on more than 
15 days 100; probable 
MOH 82                                              
PPV                                              
Migraine: 60; TTH: 69; 
headache on more than 
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15 days 100; probable 
MOH: 17                                                 
NPV                                                   
Migraine: 92; TTH 88; 
headache on more than 
15 days 99; probable 
MOH 99 
HARDSHIP 
questionnaire     
 
 Kukava et al 
(2007) 
Georgia Random sample from 
population survey (n=186) 
Neurological 
assessment by 
headache 
neurologist specialist 
Sensitivity 
Migraine: 0.75; TTH 0.79; 
migraine plus TTH 0.62 
Specificity 
Migraine: 0.96; TTH 0.86; 
migraine plus TTH 0.84 
PPV 
Migraine: 0.89; TTH 0.8; 
migraine plus TTH 0.4 
NPV 
Migraine: 0.89; TTH 0.85; 
migraine plus TTH 0.91 
HARDSHIP 
questionnaire     
 
 Rao, G. et al 
(2012) 
 
India Random sample of 
participants taking part in a 
household survey (n=381) 
 
Clinical assessment 
based on ICHD-II 
criteria by headache 
expert  
 
Sensitivity                                            
Any headache 88 (83-91)              
Migraine 63 (52-72)                           
TTH 57 (48-65)                                   
CDH 57 (48-65)                                             
Specificity                                                 
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Any headache 81 (74-87)              
Migraine 85 (81-89)                                 
TTH 81 (76-86)                                       
CDH 82 (76-86)                                               
PPV                                                        
Any headache 89 (84-92)       
Migraine 55 (45-65)                          
TTH 61 (52-69)                                      
CDH 61 (52-69)                                       
NPV                                                            
Any headache 80 (73-86)          
Migraine 89 (85-92)                               
TTH 79 (74-84)                                   
CDH 79 (74-85)                                                                                                               
Italian ICHD-II based 
questionnaire 76 
questions to diagnose 
most common primary 
headache types: 
migraine (with and 
without aura) TTH, 
probable MOH.  
Intended for use by a 
doctor in 
epidemiological studies 
Diagnostic Abrignani, G, 
et al (2011) 
Italy Consecutive patients 
referred for the first time to 
a headache centre (n=50) 
Neurological 
examination and 
assessment by 
headache specialist 
Sensitivity                                                    
Migraine with aura 100                             
Migraine without aura 
100                        TTH 100                                                      
TTH subgroup 2.3 66.6                                                         
Probable MOH 100 100                                           
Specificity                                                       
Migraine with aura 93.3  
(86-100)           Migraine 
without aura 100                                
TTH 100                                                          
22 
 
TTH subgroup 2.3 100                                                              
Probable MOH 100                                              
Headache questions as 
part of HUNT 3 study 14 
self-completed items 
including: pain intensity, 
duration and 
accompanying 
symptoms, plus over-
the-counter drugs taken 
for headache to identify:  
chronic headache, MOH, 
TTH, migraine (with and 
without aura) 
Diagnostic Hagen. K et 
al (2010) 
Norway 
 
Random sample of 
participants who had 
completed a general health 
survey in (HUNT 3 study), 
Norway (n=297) 
Semi-structured 
face-to-face 
interview by 
headache trained 
neurologist including 
clinical examination 
when indicated and 
classified in 
accordance with 
ICHD-II criteria and 
revised edition for 
MOH 
Sensitivity                                                  
TTH 96 (94-98)                                
Migraine 51 (45-57)                              
MOH 75 (70-80)                              
Chronic headache 69 (62-
74)                                                 
Specificity                                                        
TTH 69 (63-75)                                 
Migraine 95 (92-98)                                
MOH 100 (99-100)                            
Chronic headache 99 (98-
100)                            
Short self-completed 
questionnaire based on 
IHS criteria.  Questions 
on headache frequency, 
duration, location, 
character of pain, 
intensity, accompanying 
symptoms, influence on 
work/activity ability, to 
identify: migraine, TTH, 
Diagnostic  Rasmussen, 
B. et al 
(1991) 
Denmark Participants who had 
completed a  general health 
survey focusing on 
headache disorders (n=712) 
Standardised 
structured headache 
interview (using 
same questions as 
questionnaire, plus 
additional ones to 
probe on individual 
basis) plus complete 
neurological 
Sensitivity                                     
Migraine 51                                  
Episodic TTH 43                         
Chronic TTH 14                            
Specificity                                     
Migraine 92                                          
Episodic TTH 96                                    
Chronic TTH 100                              
PPV                                                
Migraine 50 
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or 'other types of 
headache' 
examination by 
neurologist 
Episodic TTH 95                            
Chronic TTH 100                              
NPV                                                   
Migraine 93                               
Episodic TTH 46                          
Chronic TTH 97                                                                                        
The Brief Headache 
Screen (BHS)                       
Short self-completed 
questionnaire - 
frequency of severe 
(disabling) headache, 
other (mild) headache 
and use of symptomatic 
medication to generate 
diagnoses of migraine, 
daily headaches and 
medication overuse                                           
Screening Maizels, M & 
Burchette, R. 
(2003) 
US Three populations:   1. 
patients seen in an 
emergency department 
with primary headaches 2. 
patients from a family 
practice, recruited from a 
sign in the waiting area 3. 
patients seen at a headache 
clinic(n=399) 
Interviewed using 
the SDMQ (Tom et al 
1994) based on IHS 
criteria to diagnose 
migraine,  asked 
about medication 
use, and then 
classified according 
to study protocol 
Sensitivity 
Chronic headache with 
migraine 93 
MOH 86 
Daily headaches 
syndromes 94 
Specificity 
Chronic headache with 
migraine 63 
MOH 79 
Daily headache 
syndromes 54 
 
German Language 
Questionnaire for 
screening migraine, TTH 
and TAC.  Based on 
ICHD-II with 20 self-
completed yes/no self-
response items. Subjects 
Screening Fritsche, G. 
et al (2007) 
Germany Consecutive patients seen 
in an outpatient headache 
clinic, plus patients with 
trigeminal autonomic 
cephalgias (TAC) recruited 
from same clinic, plus 
Face-to-face 
interview by 
headache expert 
neurologist, 
symptomatic 
headaches ruled out 
by clinical 
Sensitivity                                      
Migraine 73.2 (63.2-81.7)              
TTH 85 (73.4-92.9)                           
TAC 63.3 (52.9-72.7)                      
Mig/TTH 62.1 (42.3-79.3)                             
Specificity                                      
Migraine 96.1 (92.2-98.4)                  
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interviewed further 
about number of days 
with different headache 
types and number of 
days of acute pain or 
migraine 
healthy subjects without 
headache (n=278) 
examination, 
Doppler and duplex 
sonography and 
computer 
tomography and MRI 
when necessary 
 
 
TTH 98.2 (95.4-99.5)                       
TAC 98.8 (96-99.8)                  
Mig/TTH 97.8 (94.9-99.3)                   
PPV                                             
Migraine 91 (82.4-96.3)                   
TTH 92.7 (82.4-97.9)                           
TAC 96.9 (89.2-99.6)                
Mig/TTH 78.3 (56.3-92.5)                        
NPV                                                   
Migraine 87 (81.5-91.3)                                               
TTH 95.9 (92.5-98.1)                       
TAC 83.2 (77.5-87.9)                   
Mig/TTH 95.3 (91.8-97.6                   
One headache type  
Cluster headache 
Brief Self-Administered 
Questionnaire for 
Cluster Headache 
Screening                        2 
questions with yes/no 
responses on attack 
duration (< 180 minutes 
if untreated) and 
Screening Dousset, V. 
et al (2009) 
France Consecutive patients with a 
history of episodic or 
chronic cluster headache or 
migraine with or without 
aura seen in headache 
centre (n=96) 
Neurological 
examination by 
headache specialist 
based on ICHD-II  
Sensitivity 81.1                                                
Specificity 100                                               
PPV 100                                                             
NPV 89.4 
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conjunctival injection 
and/or lacrimation.       
Questionnaire for the 
Detection of Cluster 
Headache based on 
ICHD-II, 16 self- 
completed questions 
validated, best 
discriminatory pattern: 
unilaterality of pain and 
presence of 5 of 7 
features: pain severity 
and location, duration < 
3 to 4 hours, frequency 
and daily reoccurrence 
of attacks, rhinorrhoea 
and restlessness   
Screening Torelli, P. et 
al (2005) 
Italy Consecutive patients seen 
at headache centre, plus 
sample of patients with 
chronic cluster headache 
attending in previous 2 
years (n=71) 
Neurological 
examination by 
headache specialist, 
and if needed, 
additional 
instrumental tests.  
Initially used 1988 
IHS diagnostic 
criteria, but updated 
after ICHD-II 
published. 
Reported here for ‘best 
discriminatory pattern of 
questions’                                   
Sensitivity 100                                               
Specificity 95.1                                                     
PPV 93.8                                                             
NPV 100 
Probable Medication Overuse Headache 
Brief self-completed 
screening tool for the 
diagnosis of probable 
medication over-use 
headache (pMOH)        4 
questions adapted from 
Screening Dousset, V. 
et al (2013)   
France Consecutive headache 
patients identified by their 
GP as probable MOH and 
seen at a headache clinic for 
first time.  All primary and 
Clinical diagnosis by 
headache specialist, 
based on the second 
edition of the ICHD-
II. 
Sensitivity 81                                                
Specificity 100                                              
PPV 100                                                             
NPV 81.4                                                                                                                                                                       
Question 3 was removed 
from the analysis because 
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ICHD-II criteria: 1. Do 
you have headaches for 
more than 15 
days/month? 2. Do you 
take treatment for 
attacks more than 10 
days per month? 3. Is it 
for more than 3 
months? 4. Is drug 
intake regular? 
other secondary headaches 
excluded (n=77) 
90.5% of participants 
responded yes.  The 
results reported here are 
for questions 1,2 and 4 
Migraine 
Asian Migraine Criteria 
(AMC) Face-to-face 7 
item questionnaire: 
unilateral location, 
throbbing quality, 
nausea and/or vomiting, 
photophobia and/or 
sonophobia, 
osmophobia, family 
history of migraine and 
aura  
Screening Ghandehari, 
K. et al 
(2012) 
Iran Consecutive adults 
attending a headache clinic 
over a 6 month period.  
Patients with probable 
diagnosis of migraine based 
on ICHD-II were excluded 
(n=350) 
History based on the 
ICHD-II taken by 
headache specialist 
Sensitivity 99.3                                                     
Specificity 84.48                                              
PPV 96.93                                                            
NPV 96.08                                               
3- Question Headache 
Screen                            1. 
Screening  Cady, R. et al 
(2004)   
US Recruited from private 
physicians’ offices.  Patients 
1) IHS criteria; 2) 
clinical impression 
Overall sensitivity 77% 
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Do you have recurrent 
headaches that interfere 
with work, family, or 
social functions? 2.  Do 
your headaches last at 
least 4 hours? 3. Have 
you had new or different 
headaches in the past 6 
months? 
selected if they satisfied 1 
of 3 migraine diagnostic 
criteria: IHS criteria for 
migraine (with or without 
aura), investigators clinical 
impression, or self-report of 
recurring disabling  
headaches (n=3014) 
based on history and 
investigator's clinical 
experience or 3) 
reoccurring 
headaches based on 
self-report or expert 
questioning by 
primary care 
physicians and 
neurologists 
ID Migraine three self-
completed  questions on 
disability, nausea and 
photophobia 
 
Screening Lipton, R.B. 
et al (2003) 
US Primary care patients 
reporting ≥2 headaches in 
the previous 3 months that 
had limited their ability to 
work, study, or enjoy life or 
that they wish to consult a 
health professional about. 
After 1/3 recruitment 
completed added criteria 
that patients excluded if 
they had a previous 
diagnosis of headache 
(n=443) 
Neurological history 
and examination 
(including additional 
diagnostic tests in 
applicable) and a IHS 
based semi-
structured interview 
by headache 
specialist  Computer-
based algorithm was 
run on the IHS 
criteria and 
compared with 
clinician diagnosis 
Sensitivity 81 (95% CI, 077 
-85)   Specificity 75 (95% 
CI, 64- 84)       PPV 93.3 
(95% CI, 89.9- 95.8) 
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ID Migraine (used here 
in different settings, and 
already validated in 
Turkish) 
Screening Ertas, M. et 
al (2009) 
Turkey Patients presenting at 
ophthalmology clinics (OC), 
ENT clinics (ENTC) or 
neurology clinics (NC) 
(n=1021) 
Examination and 
interview by a 
neurologist using a 
symptom checklist 
based on IHS criteria 
and assigned to a 
clinical diagnosis of 
migraine, TTH or 
other headaches 
Sensitivity                                           
NC 87.9   ENTC 86.6   OC 
79.9                Specificity                                                
NC 74   ENTC 74.4   OC 76                           
PPV                                                           
NC 86  ENTC 80  OC 86                                 
NPV                                                           
NC 76  ENTC 83 OC 67 
Simple screening 
questionnaire: four self-
complete items: 1. Have 
you ever had migraine 2. 
Have you ever had 
severe headache 
accompanied by nausea 
3. Have you ever had 
severe headache 
accompanied by 
hypersensitivity to 
sound and light 4. Have 
you ever had visual 
disturbances lasting 5-60 
minutes followed by 
headache? 
Screening Gervil, M. et 
al (1998) 
Denmark Twins who answered yes to 
questions on headache in a 
health questionnaire were 
eligible (i.e. at least one of 
the twins had headache and 
both twins then included in 
validation study) (n=2035) 
A semi-structured 
interview designed 
for diagnosing 
headache disorders, 
with special 
emphasis on 
migraine and TTH 
(12 questions) by a 
doctor trained in 
headache diagnosis 
Sensitivity 85                                                        
Specificity 81                                                 
PPV 49                                                             
NPV 86                                                     
The sensitivity, specificity 
and predictive values 
were calculated on 
extrapolated data as only 
a proportion of those that 
answered 'no' to the four 
questions were 
interviewed.                                                                             
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Nine item self-
completed 
questionnaire including 
items from ID Migraine.  
Logistic regression used 
to determine which 
combination of items for 
highest validity  (same 
three as Lipton) 
Screening Kim, S. & 
Kim, C. 
(2006) 
Korea Patients seen in 
Temporomandibular joint 
and Orofacial Pain Clinic 
reporting ≥2  headaches in 
the previous 3 months who 
wished to consult about 
their headaches or reported 
that the headache 
interfered with their lives 
(n=176) 
Semi-structured 
diagnostic 
questionnaire based 
on IHS criteria and 
examination by 
headache specialist 
Sensitivity 58 (95% CI 45-
72)       Specificity 98 
(95%CI 76-100)                 
PPV 94 (95%CI 86-100)                   
Nausea, photophobia and 
headache-related 
disability showed the 
highest individual 
sensitivity and reported 
here                    
Migraine Screen 
Questionnaire (MS-Q)   
Five item questionnaire 
based on diagnostic 
criteria from IHS:              
frequency and intensity; 
duration of >4 hours; 
nausea; sensitivity to 
light/noise and 
headache related 
disability.       
 
Screening Lainez, M. et 
al (2005)                                      
 
 
 
 
 
 
Spain 
 
Patients from a headache 
clinic, half with diagnosis of 
migraine according to 
neurologist evaluation and 
IHS criteria, half without 
migraine (n=140)           
 
 
Neurologist assessed 
migraine according 
to IHS criteria 
 
 
 
 
 
Sensitivity 93 (95% CI, 87- 
99)                   Specificity 
81 (95% CI, 72- 91)                   
PPV 83 (CI 75- 91)                                      
NPV 92 (CI, 85- 99) 
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MS-Q 
5 self-completed 
questions requiring 
Yes/No response (as 
above).  Scored ≥ 4 
suspected migraine 
Screening Lainez, M et 
al (2010) 
 Consecutive patients 
attending primary care 
centres regardless of reason         
(n=9346) 
Primary care doctors 
diagnosed migraine 
according to their 
clinical judgement 
and IHS diagnostic 
criteria 
Sensitivity 82 (81-84)                                   
Specificity 97 (97-97)                                  
PPV 90 (89-91)                                         
NPV 94 (94-95) 
Migraine Assessment 
Tool (MAT)   Eight 
question face-to-face 
interview asked 
verbatim                             
Screening Marcus, D. 
et al (2004) 
US Community sample with a 
history of headache, 
recruited through 
advertisements (n=80) 
Headache diagnostic 
evaluation including 
history and general 
medical, neurological 
examination using 
IH-S criteria by 
neurologist 
Sensitivity 89                                                    
Specificity 79                                                   
PPV 85                                                              
NPV 84                                       
A self-completed 
questionnaire and 
algorithm based on 
modified IHS criteria  
 
 
 
 
Screening Michel, P. et 
al (1993) 
 
 
 
 
 
France 
 
1. consecutive outpatients 
from  headache clinics 
(n=171)                                                         
2. employees of a company 
consecutively detected as 
headache sufferers in their 
annual check-ups (n=96) 
Employees of a company 
who reported suffering 
from headaches at least 
once every three months 
Classified by senior 
neurologist into 
migraine or non-
migraine 
 
 
 
 
Sensitivity                                      
Sample 1 97.8  (definite 
migraine)                            
Sample 2 94.9                                            
Sample 1 95.7-99.9 
(possible mig.)                        
Sample 2 90.6 -99.2                                        
Specificity                                         
Sample 1 52.9 (definite 
mig.)                              
Sample 2 78.4                                   
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A simple self-report 
questionnaire for 
migraine 
Michel, P. et 
al (1993) 
during their annual check-
ups (n=166) 
Interview by senior 
neurologist 
specialised in the 
diagnosis and 
treatment of 
migraine 
Sample 1 45.4-60.4 
(possible mig.)                  
Sample 2 70.2-86.6                                                                                                                     
Sensitivity                                             
44 (95% CI 34.6-53.4)                                 
Specificity                                       
92.7 (95% CI 84.6-100)                                                                                                                                      
ID migraine (already 
validated in Italian by 
Brighina, F. 2005) 
 
Screening Mostardini, 
C. (2009) 
Italy Patients diagnosed with 
primary headache in an 
emergency department 
then assessed in a headache 
centre outpatient clinic 
within 48 hours of discharge 
(n=245)  
Diagnosis by 
headache specialist 
according to the 
ICHD-II criteria using 
clinical data that had 
been collected from 
the emergency 
department  
Sensitivity 94                                                            
Specificity 83                                                                             
PPV 99                                                                        
NPV 31                                                         
(The false positives for 
secondary headaches 
indicated that patients 
with cluster headache in 
particular answered 
positive to all three 
questions)                                                                  
32 
 
Three question 'decision 
tree' on headache 
frequency, laterality and 
impact on functioning  
Screening Pryse-
Phillips, W. 
et al (2002) 
Canada Participants selected by a 
neurologist with clinically 
definite migraine, TTH, or 
other headache. (n=100) 
Assessment by 
neurologist 
Sensitivity 86                                                     
Specificity 73                                                
PPV 96                                                             
NPV 38 
Patient migraine 
questionnaire, (self-
complete with support 
when needed) of 18 
items including: 
migraine history, 
duration and severity of 
headache, social 
disability, headache 
symptoms and VAS for 
pain 
Screening Wang, S. et 
al (2008) 
Taiwan Patients with chief 
complaint of headache 
attending neurology clinic 
for the first time.  Patients 
with headaches ≥ 15 days in 
one month excluded 
(n=755) 
Diagnosis of 
migraine by doctor 
using 12 item  
‘Physician’s Core 
Screening 
Questionnaire’ and 
interpreted using 
ICHD-II criteria based 
computer algorithm 
Sensitivity 73                                               
Specificity 82                                                  
PPV 91                                         
Report for each item best 
validity for three item 
combination when two of 
three items present: 
nausea/vomiting, 
photophobia and 
moderate or severe 
headache (reported here) 
Authors comment  why 
different three items than 
ID migraine- probably 
cultural as less likely to 
report headache disability                                                                                                                             
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Single item migraine 
screening test                            
1. Self-reported 
bothersome headache 
question                                  
2. Stripe pattern 
hypersensitivity 
Screening Yuan, H et al 
(2015) 
US Random sample of patients 
and their partners attending 
routine check-ups at a 
OB/GYN clinic (n=254) 
A brief structured 
interview to assess 
headache frequency, 
severity, duration, 
associated 
symptoms, disability, 
family history, 
migraine disability 
(MIDAS). Diagnosis 
made retrospectively 
using the ICHDIIIβ by 
researcher. 
1.Self-reported 
bothersome headache 
question 
Sensitivity 82                                         
Specificity 85 
PPV   81                                                       
NPV   86                                                         
2. Stripe pattern 
hypersensitivity    
Sensitivity  44                                         
Specificity  80                                               
PPV  64                                                          
NPV  65                                                         
Migraine with and without aura 
Headache questionnaire 
included in 'Nord-
Trondelag Health 
Survey (HUNT)                                  
13 self-completed 
questions based on IHS 
criteria for migraine 
xxx Hagen, K. et 
al (2000)                                     
 
Norway Random sample of 
participants who had 
completed a general health 
questionnaire which 
included questions on 
headache (n=167) 
Clinical semi-
structured interview 
by doctor 
experienced in 
headache disorders 
 
PPV 100                                                             
NPV 62 
 
The Finnish Migraine-
Specific Questionnaire 
based on the IHS, a self-
completed 
Diagnostic Kallela, M. et 
al (2001) 
Finland Stage 1 Consecutive 
patients attending 
outpatient neurological 
clinic diagnosed with 
Stage 1 Assessment 
at outpatient 
neurological clinic 
and diagnosis 
Sensitivity                                        
Stage 1  MwA 88, 
MwA+MwoA 96, MwoA 
100                                          
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questionnaire developed 
to diagnose migraine 
with and without aura in 
family studies  Particular 
attention paid to 
characteristics of 
migraine aura, and 
patients asked to 
describe aura in their 
own words        
migraine in accordance with 
IHS criteria by a neurologist 
(n=100)                            
Stage 2 Members of 
migraine families (taking 
part in another study), with 
and without migraine 
(n=94) 
according to IHS 
criteria by 
neurologist                              
Stage 2 Clinical 
telephone interview 
by neurologist with 
migraine diagnosed 
in accordance with I-
HS criteria 
Stage 2 MwA 89, 
MwA+MwoA 83 MwoA 
93, no migraine 100                        
Specificity                                            
Stage 1 MwA 97 
MwA+MwoA 96 MwoA 
100                                             
Stage 2 MwA 95 
MwA+MwOA 97 MwOA 
100 no migraine 98                     
PPV                                                 
Stage 1 MwA 78 
MwA+MwoA 98 MwoA 
100                                         
Stage 2 MwA 85 
MwA+MwoA 91 MwoA 0 
no migraine 96                            
NPV                                                   
Stage 1 MwA 98 
MwA+MwoA 93 MwoA 
100                                             
Stage 2  MwA 97 
MwA+MwoA 93 MwoA 99 
no migraine 0                                                                             
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deCODE Migraine 
Questionnaire (DMQ3) 
to diagnose migraine 
with aura and migraine 
without aura according 
to ICHD-II.  56 self-
completed questions 
and patients asked to 
describe aura in their 
own words 
Diagnostic Kirchmann, 
M. et al 
(2006) 
Denmark Random sample of  patients 
with: migraine with aura, 
migraine without aura, and 
controls from national 
patient register and 
headache clinics (n=147) 
Semi-structured 
telephone interview 
and diagnosis by 
trained doctor 
according to ICHD-II 
Time lag between 
reference and index 
2-3 years          
Sensitivity                                          
Overall 99 (97-100)                                     
MA 77 (63-90)                                    
M0 91 (81-100)                              
MA+MO 63 (48-78)                                        
Specificity                                            
Overall 86 (75-97)                                                  
MA 88 (82-94)                                                   
MO 93 (88-98)                                               
MA+MO 92 (87-97)                                                          
Structured Migraine 
Interview (SMI) brief 
self-completed (or face-
to-face/telephone 
interview) 10 item 
questionnaire based on 
ICHD II criteria for 
diagnosing migraine 
with or without aura.                     
Screening Samaan, Z.et 
al (2010) 
UK All patients registered at a 
migraine clinic were 
approached to take part 
and a random sample who 
responded were included in 
the validation exercise 
(n=200) 
Clinical diagnosis 
based on ICHD-II by 
headache specialist 
Sensitivity 87                                                 
Specificity 58                                                  
PPV 97                                                                  
NPV 26 
University of California-
San Diego (UCSD) 
Migraine Questionnaire                     
A short self-completed 
10 item questionnaire, 
distinguishes between 
Classification Tom, T. et al 
(1994) 
US Consecutive sample 
recruited from people 
referred to headache clinic, 
about half there for an 
initial consultation, and half 
Evaluation by 
neurologist using IHS 
criteria 
Sensitivity                                        
Migraine 92-94                                                         
Migraine without aura 
100                                                
Migraine with aura 71- 81                           
Specificity                                         
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non-migrainous 
headache, migraine with 
and without aura   
previously diagnosed with 
migraine (n=50) 
Migraine 100                                            
Migraine without aura 91-
94                                            
Migraine with aura 100                           
PPV                                                 
Migraine 100                           
Migraine without aura 82-
83                                                
Migraine with aura 100                           
NPV                                                
Migraine 82-88                                   
Migraine without aura  
100                                               
Migraine with aura 83-88            
(range is for agreement of 
each type of reviewer)                                               
Aura 
Visual Aura Rating Scale 
(VARS) diagnostic rating 
scale related to visual 
aura symptoms and 
characteristics (i.e. 
location, scotoma, ziz-
zag lines, duration 5-10 
mins, and whether it 
Diagnostic Eriksen, MK 
et al (2005) 
Denmark Random sample of 
participants from hospital 
registers and neurology 
outpatient departments 
(n=213) 
A trained physician 
conducted a 
telephone interview 
to diagnose 
participants based 
on the ICHD-II. 
Sensitivity                                                       
Score of ≥  5  91                         
Specificity                                        
Score of ≥ 5 96                                 
PPV                                                           
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develops gradually). 
VARS is intended as a 
supplement to the ICHD-
II. 
NPV                                                            
98 
 
Chronic Migraine 
Identify Chronic 
Migraine (ID-CM)                              
12 item online 
questionnaire, includes: 
headache frequency, 
headache symptoms 
(photo and phono 
phobia, headache 
severity, and nausea), 
prescribed and OTC 
medication in previous 
month, how often 
headache interferes 
with activities and 
making plans in last 
month. 
Classification Lipton, R et 
al (2016) 
US Participants selected from 
earlier psychometric 
validation exercise and 
CaMEO Study sample 
(n=111)  
Clinical experts using 
a Semi-structured 
Diagnostic Interview 
for Migraine (SSDI-D) 
- heavily based on 
ICHD-IIIβ 
Sensitivity 
Migraine 83.5                            
Chronic Migraine 80.6 
Specificity 88.6  
Migraine 88.5                               
Chronic Migraine 88.6 
PPV 
Migraine 96                                   
Chronic Migraine 91.5 
NPV 
Migraine 62.2                                
Chronic migraine 75 
 
Menstrual Migraine 
38 
 
 
 
 
 
 
 
 
The Menstrual Migraine 
Assessment Tool 
(MMAT) Face-to-face or 
self-completed 3 item 
questionnaire 1. Do you 
have headaches that are 
related to your period 
most months? 2. When 
the headaches are 
related to my period, 
they eventually become 
severe? 3. When my 
headaches are related to 
my period, light bothers 
me more than when I 
don't have a headache. 
Screening Tepper, S. et 
al (2008) 
US Consecutive patients 
attending a headache 
centre (n=250) 
Headache specialist 
diagnosis using 
ICHD-II criteria and 
headache diary data. 
Sensitivity 94                                                 
Specificity 74                                                   
PPV 67                                                               
NPV 95 
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Table 2. Common questions across migraine screening tools  
  
Headache 
location 
Headache 
frequency 
Headache 
duration 
Pain 
severity 
Pain 
quality 
Pain 
restricting 
activity 
Pain made 
worse by 
physical 
activity 
Nausea/ 
vomiting 
Photophobia Phonophobia Visual 
disturbance 
Cady, R. et al 
(2004)   
    x     x           
Gervil, M. et al 
(1998)       x       x x x x 
Ghandehari, K. 
et al (2012) x       x     x x x   
Lainez et at 
(2005)   x x     x   x x x   
Lipton et at 
(2003)           x   x x     
Marcus et al 
2004)  
x x x   x x x x x x x 
 Michel et al 
(1993) x x x     x x x x x   
Pryse-Phillips, 
W. et al (2002) x x       x           
Wang, S. et al 
(2008)       x       x x     
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Table 3. Quality assessment of tools 
Author Consecutive or 
random sample 
of participants
Case-control 
design 
avoided
Inappropriate 
exclusions 
avoided 
Could the 
selection of 
patients have 
introduced bias? 
Index test 
results 
interpreted 
without 
knowledge of 
the results of 
the reference 
standard 
Could the 
conduct or 
interpretation 
of the index 
test have 
introduced 
bias?  
Is the 
reference 
standard 
likely to 
correctly 
classify the 
target 
condition? 
Reference 
standard results 
interpreted 
without 
knowledge of 
the results of 
the index test?  
Could the 
reference 
standard, its 
conduct, or its 
interpretation 
have 
introduced 
bias? 
Was there an 
appropriate 
interval 
between 
index test(s) 
and reference 
standard?      
Did all 
patients 
receive a 
referenc
e 
standard
? 
Did patients 
receive the 
same 
reference 
standard? 
Were all 
patients 
included in 
the analysis? 
Could the 
patient 
flow have 
introduced 
bias?  
Overall Quality 
Score (low, 
medium or high 
risk of bias)
Abrignani, G. et al (2011)        Yes Yes Yes Low Yes Low Yes Yes Low  Yes Yes Yes Yes Low Low
Ayzenberg, I. et al (2011) Unclear Yes Yes High* Yes Low Yes Yes Low Yes Yes Yes Yes Low Low/medium*
Cady, R. et al (2004) Unclear Yes No High* No High Unclear No High* Unclear Yes No Unclear High* High*
De Simone,R. et al (2007) Unclear Yes No High* Yes Low Yes Yes Low Unclear Yes No Yes High* Medium*
Dong, Z. et al (2014) Unclear Yes Unclear High* Yes Low Yes Yes Low Unclear Yes Yes Yes Low Low/medium*
Dousset, V., et al (2013)  Yes Yes No high Yes Low Yes Yes Low Yes Yes Yes Yes Low Low/medium
Dousset,V. et al (2009) Yes Yes No High Yes Low Yes Yes Low Yes Yes Yes Yes Low Low/medium
Eriksen, M K. et al (2005) Yes Yes Yes Low No High Yes No High Yes Yes Yes Yes Low Medium
Ertas, M. et al (2009) Yes Yes No High Yes Low Yes Yes Low Yes Yes Yes Yes Low Low/medium
Fritsche, G. et al (2007) Unclear No Yes High Yes Low Yes Yes Low Yes Yes Yes Yes Low Low/medium*
Gervil, M. et al (1998) No Yes Yes High Yes Low Yes Yes Low No No Yes Yes High Medium/high
Ghandehari, K. et al (2012) Yes Yes No High Yes Low Yes Unclear High* No Yes Yes Yes High Medium/high*
Hagen, K. et al (2010) Yes Yes Yes Low Yes Low Yes Yes Low No Yes Yes Yes High Low/medium
Hagen,H. et al (2000) Yes Yes Yes Low Yes Low Yes Yes Low No Yes Yes Yes High Low/medium
Herekar, A et al (2013) Yes Yes Yes Low Yes Low Yes Yes Low Yes Yes Yes Yes Low Low
Kallela, M. et al (2001) Yes Yes No High Yes Low Yes Yes Low Yes No Yes Yes High Medium
Kim, SK, Chong-Youl Kim (2006) Unclear Yes Yes High* Unclear High* Yes Yes Low Yes Yes Yes Yes Low Medium*
Kirchmann,  E. et al (2006) Yes No No High No High Yes Yes Low No Yes Yes No High Medium/High
Kukava et al (2007) Yes Yes Yes Low Yes Low Yes Yes Low No Yes Yes No High Low/medium
Lainez,MJ , (2005) Unclear Yes No High* Unclear High* Yes Unclear High* Yes Yes Yes Yes Low Medium/high*
Lainez,MJ. (2010) Yes Yes No High Unclear High* Yes Unclear High* Yes Yes Yes No High High*
Lipton, R et al (2016) No Yes Unclear High* Yes Low Yes Yes Low Yes Yes Yes Yes Low Low/medium*
Lipton, R. et al (2003) Unclear Yes Yes High* Yes Low Yes Yes Low Yes Yes Yes No High Medium*
Maizels, M et al  (2003) Unclear Yes Yes High* Yes Low Yes No High Unclear Yes No Yes High* Medium/high*
Maizels, M, William J. Wolfe (2008) No Yes Yes High Unclear High* Yes Unclear High* Unclear No Yes Yes High* High*
Marcus,D. et al (2004) Yes Yes Yes Low Yes Low Yes Yes Low Yes Yes Yes Yes Low Low
Michel,P. (1993) Yes Yes Yes Low Yes Low Yes Yes Low Unclear Yes Yes Yes High Low/medium*
Michel,P. (1993) Unclear Yes Yes High* Yes Low Yes Yes Low Unclear Yes Yes Yes High* Medium*
Mostardini, C. et al (2009) Unclear Yes Yes High* Yes Low Yes Yes Low Yes Yes Yes No High Medium*
Pryse-Phillips,W et al (2002) Unclear Yes Unclear High* Unclear High* Unclear Unclear High* Unclear Unclear Unclear Unclear High* High*
Rao, G., (2012) Yes Yes Yes Low Yes Low Yes Yes Low Yes Yes Yes Yes Low Low
Rasmussen, B. et al (1991) Yes Yes Yes Low Yes Low Yes Yes Low Unclear Yes Yes Yes High* Low/medium*
Samaan Z ,  et al (2010) Yes Yes Yes Low Yes Low Yes Yes Low Unclear Yes Yes No High* Low/medium*
Tepper, SJ.et al (2008) Yes Yes Yes Low Yes Low Yes Yes Low Yes Yes Yes Yes Low Low
Tom, T. (1994) Yes Yes No High Yes Low Yes Yes Low Yes Yes Yes Yes Low Low/medium
Torelli, P. (2005) Yes Yes No High Yes Low Yes Yes Low Unclear Yes Yes Yes Low* Low/medium*
Wang, et al (2008) Unclear Yes No High* Unclear HIgh* Yes Unclear High* Yes Yes Yes Yes Low Medium/high*
Yuan, H et al (2015) Yes Yes Yes Low Yes Low Unclear No High* Yes Yes Yes Yes Low Low/medium*
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